|
|
my account
log out
|
Anhydro abiraterone |
| Create: 07/17/2019 |
| Expired Date: | never |
| Category: | Chemical |
| Message: | An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.https://www.bocsci.com/anhydro-abiraterone-cas-154229-20-6-item-7225.html |
![]() | |
| City: | Shirley[US]
|
| Location: |
|
| Sep 23 2019 | Y-27632 2HCl | 283 | |
| Sep 23 2019 | BMS-911543 | 299 | |
| Sep 23 2019 | JQ-1 cas 1268524-70-4 | 286 | |
| Sep 23 2019 | Alectinib | 285 | |
| Sep 23 2019 | Tubastatin A | 290 | |
| Sep 23 2019 | FLLL32 | 295 | |
| Sep 23 2019 | Thiazovivin | 294 | |
| Sep 23 2019 | Alpelisib | 292 | |
| Sep 23 2019 | Ribociclib | 268 | |
| Sep 23 2019 | Midostaurin | 291 |
| Copyright © toextrade Inc. All rights reserved. Contact us |